Abstract

The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.

1. Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
2. Scripps Oxford Laboratory, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.

Correspondence to: R.A.D. (Email: raymond.dwek@bioch.ox.ac.uk).
Author Information Reprints and permissions information is available at http://npg.nature.com/reprints/index.html

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.